Psyence Biomed

A life sciences biotechnology company focused on developing nature-derived psilocybin and ibogaine-based psychedelic medicines. $PBM

[Psyence Biomed @PsyenceBiomed]

POLITICO quotes Psyence CEO Jody Aufrichtig on ethical ibogaine. "Our goal is to lay the foundations for the use of ibogaine worldwide."
https://t.co/RHYHFuvEbB

#psychedelics #ibogaine #mentalhealth #Veterans $PBM

[Psyence Biomed @PsyenceBiomed]

We’re pleased to announce that PsyLabs is a Gold Sponsor of #ICPR2026 taking place June 4–6 in The Netherlands.

Attending from our team: Jody Aufrichtig (Psyence BioMed), Tony Budden, Dr. John Thorne, and Cody Futeran.

#Psychedelics #MentalHealth #Biotech #PsychedelicResearch

[Psyence Biomed @PsyenceBiomed]

Interesting opinion piece from Amber and Marcus Capone on the growing conversation around psychedelic-assisted therapies for veterans and the need to continue advancing research in this space.

https://t.co/lMa0Jxvp83

#psychedelics #mentalhealth #ibogaine $PBM

[Psyence Biomed @PsyenceBiomed]

Press Release - Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing.

https://t.co/37o6RwOmEd

#Psychedelics #Ibogaine #Nasdaq #FDA #NIH #USA #MentalHealth

[Psyence Biomed @PsyenceBiomed]

Proud to see Psyence BioMed featured on the @Nasdaq @NasdaqExchange Tower in Times Square as we continue advancing regulated clinical ibogaine research and GMP manufacturing infrastructure globally.

$PBM #Nasdaq #Ibogaine #Psychedelics #Biotech #MentalHealth #ClinicalResearch

[Psyence Biomed @PsyenceBiomed]

Our statement on the passing of Dr. Dan J. Stein.

#psychedelics #mentalhealth #psychiatry #psilocybin #scienceadvisory

[Psyence Biomed @PsyenceBiomed]

Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science.

Full press release and letter ⬇️

https://t.co/oSg3RIvHEj

#psychedelics #psilocybin #ibogaine #Nasdaq #longevity $PBM

[Psyence Biomed @PsyenceBiomed]

We appreciate @LongevityTech highlighting Psyence BioMed’s leadership in advancing psychedelic science and human longevity. Full story here:
https://t.co/NjULSAkLZf

#longevityscience #psychedelics #psilocybin #innovation #nasdaq $PBM

[Psyence Biomed @PsyenceBiomed]

$PBM CEO Jody Aufrichtig shares his vision for the future of longevity science and psychedelics - not to live forever, but to live better. Read the full op-ed here:
https://t.co/Ta8qfmJ7dR

#psychedelics #longevityscience #aging #antiaging #psilocybin #media

[Psyence Biomed @PsyenceBiomed]

Today, we’re proud to share we have launched the first-ever psilocybin longevity research initiative by a publicly listed company. Read the full announcement here: https://t.co/NwUA81l3IG

#psychedelics #agingscience #psilocybin #longevity #biology $PBM

[Psyence Biomed @PsyenceBiomed]

PRESS RELEASE:

https://t.co/QxVktniefk

#psychedelics #psilocybin #clinicalresearch #biotechnology $PBM

[Mugglehead Magazine @MuggleheadMag]

.@PsyenceBiomed just invested US$500K into the private South African psychedelic drug developer PsyLabs.

$PBM #psychedelics #psilocybin #ibogaine #biotech

https://t.co/ay1sBlzhng

[Psyence Biomed @PsyenceBiomed]

PRESS RELEASE: Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply.
Agreementhttps://psyencebiomed.com/investment-in-psylabs-and-global-ibogaine-supply-agreement/

$PBM #psychedelics #Ibogaine #psilocybin #biopharma #Nasdaq #PsyLabs

[Psyence Biomed @PsyenceBiomed]

@McnallieM We appreciate the coverage! Reach out anytime for another chat.

[Psyence Biomed @PsyenceBiomed]

Reminder: Psyence BioMed Corporate Webinar today at 12:00PM EST. Access the Zoom link below 👇

https://t.co/OZSQh0rkPv

#psychedelics #psilocybin #stocks #StocksToWatch #investors #biopharma $PBM

[Psyence Biomed @PsyenceBiomed]

Please join us on Thursday, April 10th @ 12:00PM EST for our first corporate webinar with $PBM CEO, Dr. Neil Maresky, CMO, Dr. Clive Ward-Able, and CFO, Warwick Corden Lloyd. See you there! #psychedelics #psilocybin #Nasdaq #biopharma

Register here ⤵️

https://t.co/MDoeZ96nbk

[Psyence Biomed @PsyenceBiomed]

Press Release: Corporate Update: Psyence Biomedical LTD Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing #psychedelics #psilocybin @Nasdaq @PsychStockWatch @Stocktwits $PBM

https://t.co/tBDveNHElV